FDA issues new patient-focused nominations

FDA is seeking public comments on disease areas it has nominated for future meetings of its patient-focused drug development (PFDD) initiative.

PFDD aims to obtain patient perspectives on specific diseases and treatments to improve the agency's ability to evaluate the benefit and risk of new drugs. ...